新诊断成人型弥漫性胶质瘤卡莫司汀晶片植入后的临床病程:单中心队列的倾向性匹配对照分析
本研究调查了2013至2023年间接受手术切除、放疗和替莫唑胺化疗的IDH野生型和突变型3-4级成人胶质瘤患者,比较卡莫司汀晶片(CW)植入组与未使用组的无进展生存期、总生存期及并发症频率。共纳入127例患者(CW组75例,未使用组52例),无论分层如何,两组PFS和OS均无显著差异;CW组术后脑水肿频率显著高于未使用组。倾向性评分匹配后生成每组41例的数据集,CW植入仍无预后影响。结论认为,在现有治疗策略下,CW植入联合标准治疗获益甚微。
要点
- CW组75例与未使用组52例相比,PFS和OS均无显著差异。
- CW组术后脑水肿频率显著高于未使用组。
- 倾向性评分匹配后每组41例,CW植入仍无预后影响。
核心结论
- CW植入联合标准治疗对当前CW使用策略显示出很小的获益效果。
研究设计与样本
- 单中心队列研究,纳入2013至2023年间接受手术切除、放疗和替莫唑胺化疗的IDH野生型和突变型3-4级成人胶质瘤患者,共127例(CW组75例,未使用组52例)。
- 采用倾向性评分匹配生成基于患者背景、诊断和切除范围的病例匹配数据集,匹配后每组41例。
主要发现
- 无论分层如何,CW使用组与未使用组的PFS和OS均无显著差异。
- CW使用组术后脑水肿频率显著高于未使用组。
- 倾向性评分匹配后,CW植入仍无预后影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: It remains unclear whether combining carmustine wafer (CW) implantation with the standard treatment for adult-type diffuse gliomas is safe and has a prognostic impact. This study aimed to investigate the prognostic value and safety of CW implantation. METHODS: Adult patients with IDH-wild-type and -mutant gliomas, grades 3-4 treated with surgical resection, radiotherapy, and temozolomide chemotherapy between 2013 and 2023 were surveyed. CWs were implanted except in cases of intraoperative wide ventricle opening or marked preoperative brain swelling. For survival analyses, a case-matched dataset based on propensity score matching (PSM), including multiple factors (patient background, diagnosis, and extent of resection) was generated. Progression-free survival (PFS), overall survival (OS), and frequency of complications of CW implantation (brain edema, infection, and cerebrospinal fluid leakage) were compared between the CW and non-use groups. RESULTS: In total, 127 patients (75 in the CW use group and 52 in the non-use group) were enrolled. Regardless of stratification, no significant differences in PFS and OS were observed between the CW use and non-use groups. The frequency of postoperative brain edema was significantly higher in the CW use group than in the non-use group. An adjusted dataset containing 41 patients in the CW use and nonuse groups was generated. Even after PSM, CW implantation had no prognostic effect. CONCLUSIONS: CW implantation with standard treatment demonstrated little beneficial effect for the present strategy of CW use.
引用
- Ono T, Suzuki H, Nanjo H, et al. Clinical Course after Carmustine Wafer Implantation for Newly Diagnosed Adult-type Diffuse Gliomas; A controlled propensity matched analysis of a single center cohort. J Neurooncol. 2024. PMID: 38780714. doi:10.1007/s11060-024-04679-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。